Personalized Medicine in Oncology Market By Application: Targeted Therapy, Biomarker Testing, By End-Use: Hospitals, Clinics, By Region: North America, Europe, Asia Pacific, Segment Forecasts: 2024 - 2030
Personalized Medicine in Oncology Market Trends
The personalized medicine in oncology market was valued at USD 45.2 billion in 2024 and is expected to grow at a CAGR of 10.7% from 2025 to 2030. Personalized medicine is revolutionizing cancer treatment by enabling tailored therapies based on individual patient profiles.
Product Insights
Targeted therapy applications dominated the market in 2024, contributing 64.5% of total revenue. Advances in biomarker testing are facilitating the development of personalized treatments, leading to improved patient outcomes.
End-Use Insights
Hospitals represented the largest end-use segment in 2024, holding a 70.9% market share, as they adopt personalized therapies to enhance treatment efficacy. Clinics are also increasingly integrating personalized approaches into their oncology practices.
Regional Insights
North America accounted for a significant share of the personalized medicine in oncology market, with 47.1% in 2024, driven by high adoption rates of advanced treatment modalities. The Asia Pacific region is projected to experience substantial growth, with a CAGR of 12.5%, as awareness of personalized medicine increases.
GET A FREE SAMPLE
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.